MedTrace Logo

Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

NCT00493948 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2009-11-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate an approved, portable device for assessing Sleep Disordered Breathing in Congestive Heart Failure.

Conditions

  • Heart Failure, Congestive
  • Sleep Apnea Syndromes

Interventions

DEVICE

ApneaLink

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Rachel A Coxon, BE/MBiomedE · ResMed/The University of New South Wales

  • Klaus Schindhelm, PhD · ResMed/The University of New South Wales

  • Jodie Lattimore, PhD · Royal Prince Alfred Hospital, Sydney, Australia

  • Ian Wilcox, PhD · Royal Prince Alfred Hospital/The University of Sydney

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00493948 on ClinicalTrials.gov